A New Front Line Is Taking Shape in Metastatic Renal Cell Carcinoma

The dismal prognosis for patients with metastatic renal cell carcinoma (mRCC) has fueled an earnest quest for more effective treatments, culminating in a better understanding of the disease and regulatory approval of several new drugs and therapeutic combinations.10/04/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news